1. Food and Drug Administration (FDA).(). . . In [ pp. ] . . approval of clotrimazole 1% cream and 100 mg inserts on November 30, 1990, Ingredients and Dosages Transferred from Rx-to-OTC Status, FDA's Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, October 2002
2. Weisberg, M and Summers, P. (1996) Patient self-diagnosis of vulvovaginal candidiasis Female Patient, 21, pp. 60 - 4.
3. Sihvo, S and Ahonen, R and Mikander, H and Hemminki, E. (2000) Self-medication with vaginal antifungal drugs: physician's experiences and women's utilization patterns Fam Pract, 17, pp. 145 - 9.
4. Ferris, D and Nyirjesy, P and Sobel, J and Soper, D and Pavletic, A and Litaker, M. (2002) Over-the-counter antifungal drug misuse associated with patientdiagnosed vulvovaginal candidiasis Obstet Gynecol, 99, pp. 419 - 25.
5. Roy, S and Caillouette, J and Faden, J and Roy, T.The role of an over-the-counter vaginal pH device package insert: can subjects learn what the device is for and how to use it? (submitted for publication).